Table 5 Results of sensitivity analysis on the economic cost per IPTi dose delivered. Figures are United States cents, year 2005 (Tsh1205 = US$1)
Variables | Financial | Opportunity | Economic cost (Total) |
|---|---|---|---|
Base case results | 17.68 | 5.11 | 22.79 |
Low EPI coverage (71% nationwide) | 23.41 | 6.76 | 30.18 |
Exclude sensitization at community level | 16.92 | 4.00 | 20.9 |
Use of local brand SP Drug | 8.44 | 4.85 | 13.29 |
Increase in salaries and per diem | 20.97 | 5.74 | 26.71 |
Using generic drug, increasing salaries, excluding sensitization and lower EPI coverage | 22.40 | 5.28 | 27.68 |